NICE has completed a rapid evidence summary on the off-label use of eculizumab (Soliris, Alexion Pharma UK) for managing dense deposit disease (DDD), a form of the rare kidney condition C3 glomerulopathy.
27 June 2015
The National Institute for Health and Care Excellence (NICE) has published a draft health and social care guideline to help manage the complicated needs of adults being admitted to and discharged from hospital who are receiving or need support from social care.
25 June 2015
NICE has today published preliminary recommendations on ciclosporin (Ikervis, Santen Pharmaceutical) for treating severe keratitis(1) in adults with dry eye disease which has not improved despite treatment with artificial tears, and has asked for more information from the company.
24 June 2015